← The Wire
PRMENasdaq
Prime Medicine, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1894562
Developing genetic medicines using Prime Editing to treat diseases driven by genetic alterations
red 8-K · 90d
$501M
Market cap
$3.72
Last close
+8.4%
1D
+10.4%
5D
5.3M
Volume
Price · last 39 sessions+7.2%
May 4L $2.70 · H $3.72Jun 29
81
Total filings
Jun 8, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 8, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 2026DEFA14ADEFA14AApr 23, 2026DEF 14ADEF 14AApr 23, 20268-KExecutive ChangeApr 16, 202610-K10-KMar 3, 20268-KResults of Operations · Reg FD DisclosureMar 3, 20268-KReg FD DisclosureJan 12, 202610-Q10-QNov 7, 20258-KResults of OperationsNov 7, 20258-KReg FD DisclosureSep 8, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KExecutive Change · Shareholder VoteAug 5, 20258-KMaterial AgreementJul 31, 2025424B5424B5Jul 31, 2025424B5424B5Jul 30, 20258-KResults of Operations · Company UpdateJul 30, 20258-KExecutive ChangeJul 15, 2025DEF 14ADEF 14AJul 14, 20258-KShareholder VoteJun 5, 2025DEFA14ADEFA14AMay 19, 20258-KExecutive Change · Reg FD DisclosureMay 19, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 2025DEFA14ADEFA14AApr 22, 2025DEF 14ADEF 14AApr 22, 20258-KReg FD Disclosure · Company UpdateMar 18, 202510-K10-KFeb 28, 20258-KResults of OperationsFeb 28, 20258-KReg FD DisclosureJan 13, 202510-Q10-QNov 12, 20248-KResults of OperationsNov 12, 20248-KReg FD DisclosureOct 24, 20248-KMaterial Agreement · Equity IssuanceSep 30, 202410-Q10-QAug 8, 20248-KResults of OperationsAug 8, 20248-KBylaw Amendment · Shareholder VoteJun 12, 2024DEFA14ADEFA14AMay 21, 20248-KBylaw AmendmentMay 21, 202410-Q10-QMay 10, 20248-KResults of OperationsMay 10, 2024DEFA14ADEFA14AApr 29, 2024DEF 14ADEF 14AApr 29, 202410-K10-KMar 1, 20248-KResults of OperationsMar 1, 2024SC 13DARCH VENTURE FUND XII, L.P. - PRIME MEDICINE -- SCH 13DFeb 22, 20248-KMaterial AgreementFeb 16, 2024424B5424B5Feb 16, 2024424B5424B5Feb 14, 20248-KResults of OperationsFeb 14, 20248-KReg FD DisclosureJan 8, 20248-KCompany UpdateJan 5, 20248-KExecutive ChangeJan 5, 202410-Q10-QNov 3, 20238-KResults of OperationsNov 3, 202310-Q10-QAug 7, 20238-KResults of Operations · Reg FD DisclosureAug 7, 20238-KShareholder VoteJun 16, 20238-KReg FD DisclosureMay 17, 202310-Q10-QMay 11, 2023DEFA14ADEFA14AMay 11, 20238-KExecutive ChangeMay 11, 20238-KResults of OperationsMay 11, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 20238-K/AResults of OperationsMar 10, 202310-K10-KMar 9, 20238-KResults of OperationsMar 9, 2023SC 13GARCH VENTURE FUND X, L.P. - PRIME MEDICINE, INC. -- SCH 13GFeb 13, 2023SC 13GSC 13GFeb 10, 2023SC 13GSC 13GFeb 7, 20238-KReg FD DisclosureJan 9, 202310-Q10-QNov 14, 2022SC 13GSC 13GOct 26, 20228-KBylaw AmendmentOct 24, 2022424B4424B4Oct 21, 2022S-1/AS-1/AOct 17, 2022S-1/AS-1/AOct 13, 2022
Similar companies
Comparable business profile · signals at a glance